Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
Nuclear Medicine and Biology|May 29, 2002
N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligandsRobin J Tyacke, Emma S J Robinson, Rebecca Schnabel, et al.Brain Research|May 5, 2009
Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding siteAtsuko Kimura, Robin J Tyacke, James J Robinson, et al.The Journal of Pharmacology and Experimental Therapeutics|August 24, 2019
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in RatsLisa R Gerak, Vanessa Minervini, Elizabeth Latham, et al.ACS Chemical Neuroscience|January 14, 2014
Characterization of BU09059: a novel potent selective κ-receptor antagonistJoseph J Casal-Dominguez, Daniel Furkert, Mehrnoosh Ostovar, et al.Proceedings of the National Academy of Sciences of the United States of America|August 31, 2016
A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primatesHuiping Ding, Paul W Czoty, Norikazu Kiguchi, et al.Mindfulness|August 14, 2018
Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of EcstasySunjeev K Kamboj, Ylva S E Walldén, Caroline J Falconer, et al.Journal of Medicinal Chemistry|October 22, 2009
14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonistsNick P R Nieland, David Rennison, Jillian H Broadbear, et al.Journal of Medicinal Chemistry|August 18, 2006
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinonesNick P R Nieland, Humphrey A Moynihan, Simon Carrington, et al.Journal of Medicinal Chemistry|June 13, 2003
Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agentsJianjing Cao, Santosh S Kulkarni, Stephen M Husbands, et al.Psychopharmacology|March 30, 2007
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonistsGregory T Collins, Amy Hauck Newman, Peter Grundt, et al.Pageof 11